亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Role and Outcome of Endovascular Management for Surgical High Risk Patients with TASC II D Femoropopliteal occlusive Disease: A Single Center Study

医学 外科 狭窄 前瞻性队列研究 闭塞 再狭窄 严重肢体缺血 队列 截肢 血管疾病 支架 放射科 动脉疾病 内科学
作者
Amr Nabil Kamel,Mohamed Zaki,Amr A. Mahmoud
出处
期刊:Ain-Shams Journal of Surgery 卷期号:20 (1): 35-40
标识
DOI:10.21608/asjs.2019.178068
摘要

Background: Peripheral arterial disease (PAD) is a medical condition of growing magnitude that usually results from atherosclerosis and subintimal cholesterol deposition leading to stenosis or occlusion in the major arteries supplying the lower extremities.Worldwide prevalence of PAD is estimated to be around 10%.In general, bypass surgery is better adopted for long SFA occlusive lesions of more than 25cm length.Using an autologous vein graft is generally more preferable, especially whenever the patient's general condition permits, provided that the patient's life expectancy is more than 2 years.Endovascular treatment is an attractive alternative to open surgical procedures for PAD. Aim of the work:This prospective cohort study aimed at detecting the role of endovascular management for surgical high risk patients with TASC II D femoro-popliteal occlusive diseases.The primary end point was limb salvage, and secondary end points included amputation free survival, binary restenosis.Patients and methods: This is a prospective non randomized cohort study which included 54 surgical high risk patients with TASC II D femoro-popliteal occlusive diseases .It is a single arm clinical study with no comparison with open surgery result.The protocol was approved by the local ethics committee of Ain Shams University hospitals and all patients signed an informed consent form.Results: 54 patients were included: 14 men (25.9%) and 40 women (74.1%).Technical success was reported in 48/54 cases (88.9%), and 6 cases failed (5 received bypass, 1 underwent major amputation).The primary patency within 2 years was 70.9%, assisted primary patency was 73.33 % and secondary patency was 68.18%. Conclusion:Endovascular management has an effective role in the treatment of TASC II D femero-popliteal occlusive diseases in surgical high risk patients and the limb salvage.Drug eluting balloons have lower incidence of restenosis and need for intervention in comparison to standard balloon.Stent insertion is associated with high incidence of re-intervention in comparison to balloon only angioplasty.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
勿念发布了新的文献求助20
4秒前
斯内克完成签到,获得积分10
5秒前
光亮千易完成签到,获得积分10
11秒前
勿念完成签到,获得积分20
21秒前
科研路上互帮互助,共同进步完成签到 ,获得积分10
27秒前
28秒前
云墨完成签到 ,获得积分10
32秒前
32秒前
无名子完成签到 ,获得积分10
32秒前
Phyllis发布了新的文献求助10
33秒前
33秒前
ConquerorXv发布了新的文献求助10
38秒前
外向的以莲完成签到,获得积分10
38秒前
科研通AI6.4应助随风采纳,获得10
39秒前
JamesPei应助Phyllis采纳,获得10
44秒前
52秒前
双双完成签到 ,获得积分10
57秒前
随风发布了新的文献求助10
59秒前
脑洞疼应助yym采纳,获得10
1分钟前
1分钟前
lsh完成签到 ,获得积分10
1分钟前
流禾乙豫完成签到 ,获得积分10
1分钟前
1分钟前
蓓蓓完成签到 ,获得积分10
1分钟前
123关闭了123文献求助
1分钟前
1分钟前
1分钟前
luang应助gjww采纳,获得50
1分钟前
gsonix完成签到 ,获得积分10
1分钟前
cen发布了新的文献求助10
1分钟前
Phyllis发布了新的文献求助10
1分钟前
1分钟前
霖羊发布了新的文献求助10
1分钟前
xxzxg_nono完成签到,获得积分10
1分钟前
yym发布了新的文献求助10
1分钟前
火星上雨南完成签到,获得积分10
1分钟前
稳重幻嫣应助cen采纳,获得10
1分钟前
李健的小迷弟应助Phyllis采纳,获得10
1分钟前
YYL完成签到 ,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
China Pluperfect I: Epistemology of Past and Outside in Chinese Art 520
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Cosmos as Art Object: Studies in Plato's Timaeus and Other Dialogues 500
What is the Future of Psychotherapy in Digital Age? Technology, AI Bots, and Psychotherapy after Covid 444
Management and the Arts 310
Teaching Social and Emotional Learning in Physical Education 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7633533
求助须知:如何正确求助?哪些是违规求助? 9207696
关于积分的说明 19747984
捐赠科研通 7202222
什么是DOI,文献DOI怎么找? 3274951
关于科研通互助平台的介绍 2436900
邀请新用户注册赠送积分活动 2271814